Lv2
130 积分 2024-08-27 加入
DNMT3A Mutations Independently Predict Poor Outcome in Older AML Patients: A SWOG Report,
18天前
已关闭
Long-term tolvaptan therapy in a case of very early-onset polycystic kidney disease
19天前
已完结
Clinical features and mutational spectrum of Chinese patients with primary hyperoxaluria type 2
1个月前
已完结
Comprehensive genetic sequence and copy number analysis for Charcot-Marie-Tooth disease in a Canadian cohort of 2517 patients
1个月前
已关闭
Comprehensive Molecular Diagnostics in Autosomal Dominant Polycystic Kidney Disease
1个月前
已关闭
Identification of deleterious variants in nine polycystic kidney disease affected families
1个月前
已完结
Novel PKD1 and PKD2 mutations in Taiwanese patients with autosomal dominant polycystic kidney disease
2个月前
已完结
Role of LEDGF/p75 (PSIP1) in oncogenesis. Insights in molecular mechanism and therapeutic potential
2个月前
已完结
Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients
5个月前
已完结
Characterization of 223 infants with CFTR-related metabolic syndrome/Cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID) identified during the first three years of newborn screening via IRT-DNA-SEQ in New York State
6个月前
已完结
皖公网安备34019202002308
